Ann: Shareholder Newsletter, page-6

I couldn't even see a mention of the recent DEP® Research Agreement with Genentech in today's newsletter either ?




I did however raise my concerns re: India this morning in this post below .... > 6 months since registration approval in India with no distribution agreement for Viraleze in the middle of a pandemic .... something smells




https://hotcopper.com.au/threads/new-africa-variant.6448058/page-48?post_id=58326167#.YbrGHWhBzIU


The fact remains @stoway they can say in their marketing that they have done a human trial regardless if it is flawed ….. so can SaNOtize who are running a subsequent trial in guess where - India


https://www.biospace.com/article/re...notize-s-breakthrough-treatment-for-covid-19/


There is some reason the India registration has gone nowhere in 6 months … what could it be ?